Cargando…
Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines
Glioblastoma multiforme (GBM) is the most prevalent form of malignant brain tumor. Amlexanox, a novel compound, has been shown to have anti-cancer potential. In this study, the anti-tumoral effects and the underlying mechanisms of amlexanox were investigated. Amlexanox significantly suppressed proli...
Autores principales: | Liu, Yang, Lu, Jie, Zhang, Zhimeng, Zhu, Lin, Dong, Shicai, Guo, Gaochao, Li, Ruohong, Nan, Yang, Yu, Kai, Zhong, Yue, Huang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596579/ https://www.ncbi.nlm.nih.gov/pubmed/29048430 http://dx.doi.org/10.1038/cddis.2017.396 |
Ejemplares similares
-
IKBKE regulates cell proliferation and epithelial–mesenchymal transition of human malignant glioma via the Hippo pathway
por: Lu, Jie, et al.
Publicado: (2017) -
Amlexanox Enhances Temozolomide-Induced Antitumor
Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR
Signaling Pathway
por: Xiong, Jinbiao, et al.
Publicado: (2021) -
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway
por: Wang, Xin, et al.
Publicado: (2021) -
IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway
por: Bainbridge, Alex, et al.
Publicado: (2020) -
IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway
por: Yi, Li, et al.
Publicado: (2020)